Blackwell Kimberly 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 5, 2024
Insider Transaction Report
Form 4
Blackwell Kimberly
Director
Transactions
- Tax Payment
Common Stock
2024-02-01$11.69/sh−20,655$241,457→ 484,145 total - Award
Common Stock
2024-02-01+250,000→ 504,800 total - Award
Stock Option (Right to Buy)
2024-02-01+250,000→ 250,000 totalExercise: $11.69Exp: 2034-01-31→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date, subject to the Reporting Person's continued service with the Issuer.
- [F2]Shares automatically withheld to satisfy tax obligations upon the vesting of restricted stock units previously granted to the Reporting Person.
- [F3]The options will vest over four years in equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.